Additionally, the level of plasma soluble CX3CL1 was found to be significantly greater in the patients with mild to moderate AD than in the patients with severe AD, and the level of CX3CL1 is inversely correlated to AD severity (Kim et al., 2008), suggesting an early neuroinflammatory role in AD pathogenesis. This evidence concerns the gene CX3CL1 and Alzheimer disease.